Skip to main content

TXMD

TherapeuticsMD, Inc.

Company with tickers: TXMD

CIK
25743
CUSIP
88338N206
Shares Outstanding
11,574,362
13F Activity (30d)
42 filings 40 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 50
Total Value: $8,018,871
Total Shares: 3,969,749

Institutional Ownership Trend

18 quarters

Holder Concentration

Across 50 13F filers · Δ vs Dec 31, 2025
Top Holder
30.0%
Jun 2023 → Mar 2026 · range 30.0% – 39.2%
−4.6 pts
Top 5
74.2%
Jun 2023 → Mar 2026 · range 74.2% – 85.2%
−6.7 pts
Top 10
92.1%
Jun 2023 → Mar 2026 · range 92.1% – 97.6%
−3.5 pts
HHI
1,504
Jun 2023 → Mar 2026 · range 1,504 – 2,128
Moderately concentrated −360

Quarterly Activity

vs Dec 31, 2025
New
10
Increased
8
Decreased
9
Sold Out
5
Unchanged
23
Holder count: +5
Institutional value: +42.9%
Shares held: +15.3%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 51 of 51
Export CSV
Holder Value (USD) % of 13F Shares Open